Picture of Bausch + Lomb logo

BLCO Bausch + Lomb Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareBalancedLarge CapTurnaround

Annual cashflow statement for Bausch + Lomb, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSARSARSARSARS
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line19315-248-305-352
Depreciation
Deferred Taxes
Non-Cash Items12160146198228
Unusual Items
Other Non-Cash Items
Changes in Working Capital28-19-287-8718
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Payable / Accrued Expenses
Cash from Operating Activities873345-17232283
Capital Expenditures-193-175-181-291-349
Purchase of Fixed Assets
Other Investing Cash Flow Items-21-40-1,928-121-106
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-214-215-2,109-412-455
Financing Cash Flow Items-712-2,346-37-23-36
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities-712812,078178225
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-61203-46-1881